CFO transition
Neuronetics, Inc. CFO transition: Nir Naor to succeed W. Andrew Macan
Neuronetics, Inc. reported in a Form 8-K filed July 20, 2026 that Nir Naor will succeed W. Andrew Macan as Executive Vice President, Chief Financial Officer, and Treasurer, effective July 23, 2026.
In the filing's words
On July 9, 2026, the Board appointed Nir Naor as the Company’s Executive Vice President, Chief Financial Officer, and Treasurer with an effective date on or about July 23, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Neuronetics, Inc. (STIM) |
|---|---|
| Event | Transition |
| Incoming | Nir Naor |
| Outgoing | W. Andrew Macan |
| Title in the filing | Executive Vice President, Chief Financial Officer, and Treasurer |
| Effective | July 23, 2026 |
| 8-K filed | July 20, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, Axogen, Inc. (NASDAQ: AXGN) |
| SEC CIK | 0001227636 |
Neuronetics, Inc. reported this change in a Form 8-K, Item 5.02, filed July 20, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Nir Naor? Send a correction with the primary source.